Table 2.
Indirect antioxidants | Effect on target organ toxicity |
---|---|
Sulforaphane |
Protection against tumor formation induced by many carcinogens: mammary, colon, lung, pancreatic, gastric, intestine, skin, and bladder (mouse, rat, hamster) [16,111,112,113,114,115] |
D3T |
Inhibition of aflatoxin B1 induced hepatic tumorigenesis (rat) [116,117]. |
Oltipraz |
Inhibition of carcinogenesis induced by various carcinogens in bladder, colon, kidney, liver, lung, pancreas, and stomach (mouse, rat) [116,118,119]. |
Resveratrol |
Inhibition of growth of variety tumors: skin, breast, gastric, colon, small intestine, lung, esophageal, prostate, liver, and pancreatic cancers (mice, rat) [120,121,122]. Human clinical trials in breast cancer patients [123]. |
Curcumin |
Inhibition of tumor development in skin, liver, oral, esophageal, stomach, intestinal, colon, and bladder (mouse, rat) [124]. Human clinical trials in patients with advanced pancreatic cancer and other disease [125,126]. |
CAPE |
Anti-proliferation property in cancer cells [127]. |